These findings are consistent with previous reports of reduced circulating NRG4 in individuals with MASLD, metabolic syndrome, gestational diabetes mellitus, chronic kidney disease, and diabetic peripheral neuropathy (29-33). This evidence concerns the gene NRG4 and chronic kidney disease.